Documents & Downloads

CCG-232964

Rho/MRTF/SRF Inhibitor

CCG-232964 is a potent oral inhibitor of the Rho/MRTF/SRF signaling pathway. It effectively inhibits lysophosphatidic acid (LPA)-induced connective tissue growth factor (CTGF) gene expression, making it a valuable tool for studying fibrogenesis and related cellular processes. This compound is useful for researchers investigating mechanisms of cellular differentiation and tissue remodeling.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2349373-70-0
Applications	Rho/MRTF/SRF Inhibitor
Formula	C₁₅H₁₅ClN₂O₃S
Molecular Weight	338.81
SMILES	O=C(O)CCCSC1=NN=C(C2=CC=C(C3CC3)C=C2Cl)O1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.